Strong expression of Pdpn in high-grade gliomas was reported and proposed as a potential indicator for malignant progression and poor prognosis in glioma patients (Mishima et al., 2006; Ernst et al., 2009; Peterziel et al., 2012). The gene discussed is PDPN; the disease is central nervous system cancer.